Is HMACW or MRK a better dividend investment in 2026?

HMACW currently yields 2222.22% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: HMACW offers higher current income.

What is the dividend yield difference between HMACW and MRK?

HMACW has a forward dividend yield of 2222.22% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 2218.97 percentage points.

Home › Compare › HMACW vs MRK

HMACW vs MRK: Dividend Comparison 2026

HMACW yields 2222.22% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HMACW wins by $26607504688.23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HMACW

● Live price

2222.22%

Share price

$0.09

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26607504688.26M

Annual income

$24,443,703,761,807,280.00

Full HMACW calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — HMACW vs MRK

📍 HMACW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HMACW	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HMACW + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HMACW pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HMACW

Annual income on $10K today (after 15% tax)

$188,888.89/yr

After 10yr DRIP, annual income (after tax)

$20,777,148,197,536,188.00/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, HMACW beats the other by $20,777,148,197,535,380.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HMACW + MRK for your $10,000?

HMACW: 50%MRK: 50%

100% MRK50/50100% HMACW

Portfolio after 10yr

$13303752344.14M

Annual income

$12,221,851,880,904,116.00/yr

Blended yield

91.87%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HMACW

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HMACW buys

MRK buys

No recent congressional trades found for HMACW or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHMACWMRK

Forward yield	2222.22% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$26607504688.26M ✓	$30.7K
Annual income after 10y	$24,443,703,761,807,280.00 ✓	$950.29
Total dividends collected	$26455115546.17M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: HMACW vs MRK ($10,000, DRIP)

Year	HMACW Portfolio	HMACW Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$232,922	$222,222.22	$11,192	$351.54	+$221.7K → HMACW
2	$5,086,656	$4,837,429.33	$12,524	$392.70	+$5.07M → HMACW
3	$104,173,443	$98,730,720.93	$14,015	$438.65	+$104.16M → HMACW
4	$2,001,166,924	$1,889,701,340.37	$15,682	$489.96	+$2001.15M → HMACW
5	$36,067,485,611	$33,926,237,001.88	$17,547	$547.23	+$36067.47M → HMACW
6	$610,050,404,477	$571,458,194,873.63	$19,632	$611.16	+$610050.38M → HMACW
7	$9,686,139,336,337	$9,033,385,403,546.24	$21,963	$682.53	+$9686139.31M → HMACW
8	$144,409,519,569,037	$134,045,350,479,156.38	$24,571	$762.18	+$144409519.54M → HMACW
9	$2,022,243,856,495,371	$1,867,725,670,556,501.50	$27,486	$851.08	+$2022243856.47M → HMACW
10	$26,607,504,688,257,330	$24,443,703,761,807,280.00	$30,745	$950.29	+$26607504688.23M → HMACW

HMACW vs MRK: Complete Analysis 2026

HMACW — Stock

Hainan Manaslu Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. The company was founded in 2021 and is based in Haikou, China.

Full HMACW Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this HMACW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HMACW vs SCHD HMACW vs JEPI HMACW vs O HMACW vs KO HMACW vs MAIN HMACW vs JNJ HMACW vs ABBV HMACW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.